Microcystic Adnexal Carcinoma

• DOI: 10.1001/archderm.136.11.1355
• Publication Date: 2004-03-01T18:45:19Z
• Authors: Katarina Chiller; Douglas Passaro; Michael Scheuller; Mark Singer; Timothy McCalmont; Roy C. Grekin
• Keywords: Mohs surgery; Adnexal Diseases; Mucinous carcinoma

<h3>Background</h3> Microcystic adnexal carcinoma, or sclerosing sweat duct is an uncommon cutaneous neoplasm associated with extensive local invasion. The standard of care regard to the best excisional method in treating microcystic carcinoma has not been established. <h3>Objectives</h3> To perform a retrospective study comparing patients treated by Mohs micrographic surgery those wide excision and elucidate epidemiological features carcinoma. <h3>Patients Methods</h3> A analysis case series involving 48 primary referral diagnosed as having using standardized criteria. All cases were reviewed same dermatopathologists. <h3>Results</h3> predominantly affects left side face middle-aged women. misdiagnosed 30% time. recurrence rate 1.98% per patient-year. simple show comparable complication rates. Clear margins obtained fewer procedures and, therefore, office visits when lesions surgery. defect surface area after full extirpation following was mean 4 times that clinically apparent size. range difference between pre– post–Mohs noted our data indicates margin cannot be safely predicted. <h3>Conclusions</h3> left-sided, locally aggressive facial tumor, which results significant morbidity. Our do support use predictable margins. reasonable initial treatment, it accomplishes cure does rely on predicted